Emerging roles of the cancerous inhibitor of protein phosphatase 2A (CIP2A) in ovarian cancer
Abstract Ovarian cancer (OvCa) is the sixth most common gynaecological cancer in the UK, accounting for over 200,000 deaths worldwide. Cancerous Inhibitor of Phosphatase 2 A (CIP2A) is an oncoprotein and an endogenous inhibitor of PP2A. CIP2A is a key regulator for cellular processes (e.g. prolifera...
Saved in:
| Main Authors: | Alice Filipe, Sayeh Saravi, Denis Mustafov, Suzana Panfilov, Simran Banger, Seyedehnajmeh Mousavikivaj, Maria Braoudaki, Senthilkumar Kailasam, Yasser Riazalhosseini, Michelle A. Sahai, Fotios Drenos, Cristina Sisu, Emmanouil Karteris |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-05013-0 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
ETS1 mediates MEK1/2-dependent overexpression of cancerous inhibitor of protein phosphatase 2A (CIP2A) in human cancer cells.
by: Anchit Khanna, et al.
Published: (2011-03-01) -
CIP2A promotes inflammation and exacerbates osteoarthritis by targeting CEMIP
by: Jingyue Su, et al.
Published: (2025-06-01) -
Association between alkaline phosphatase and cancer in American adults: 2003–2016 NHANES
by: Qian Wu, et al.
Published: (2025-07-01) -
New microRNA-based therapies reveal common targets in paediatric medulloblastoma and adult glioblastoma
by: Denis Mustafov, et al.
Published: (2025-07-01) -
Nanozymes with phosphatase-like activity
by: Yu Cao, et al.
Published: (2025-08-01)